David Henry Mack

CIK: 0001341642

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (9.1%)

Position reduction

Option Exercises (M)3 (27.3%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)3 (27.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMVP

PMV Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

PMVP
PMV Pharmaceuticals, Inc.
Mar 5, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
745K shares-
PMVP
PMV Pharmaceuticals, Inc.
Oct 27, 2025
Exercise(M)
Direct
220.6K shares at avg. $1.37$302K
PMVP
PMV Pharmaceuticals, Inc.
Jul 1, 2025
Sale(S)
Direct
58.4K shares at avg. $1.06$62K
PMVP
PMV Pharmaceuticals, Inc.
Mar 3, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
800K shares-
PMVP
PMV Pharmaceuticals, Inc.
Jan 3, 2025
Exercise(M)
Direct
17.7K shares at avg. $0.53$9K
PMVP
PMV Pharmaceuticals, Inc.
Dec 3, 2024
Exercise(M)
Direct
91.8K shares at avg. $0.53$49K
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
249.6K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
330K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
330K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
384.2K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
134.6K shares-

		Type	Shares	Price		Ownership
Mar 5, 2026	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	744,960	-	-	Direct
Oct 27, 2025	PMVP PMV Pharmaceuticals, Inc.	Exercise(M)	220,643	$1.37	$302,281	Direct
Jul 1, 2025	PMVP PMV Pharmaceuticals, Inc.	Sale(S)	58,411	$1.06	$62,179	Direct
Mar 3, 2025	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	800,000	-	-	Direct
Jan 3, 2025	PMVP PMV Pharmaceuticals, Inc.	Exercise(M)	17,709	$0.53	$9,386	Direct
Dec 3, 2024	PMVP PMV Pharmaceuticals, Inc.	Exercise(M)	91,750	$0.53	$48,628	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	249,600	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	330,000	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	330,000	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	384,184	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	134,584	-	-	Direct

1-11 of 11 transactions

About Mack David Henry

Mack David Henry (SEC CIK 0001341642) files insider reports with the SEC as President and CEO of PMV Pharmaceuticals, Inc. (PMVP).

Signal8 holds 6 ownership filings by Mack David Henry, all Form 4s, filed between Oct 3, 2024 and Mar 9, 2026. Those filings report 11 transactions, from Aug 13, 2024 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mack David Henry's filings is in PRINCETON, NJ.

Recent filings by Mack David Henry

Mar 5, 2026: Grant or award of PMVP derivative securities (Form 4, code A).
Oct 27, 2025: Option exercise of PMVP shares (Form 4, code M).
Jul 1, 2025: Open-market sale of PMVP shares (Form 4, code S).
Mar 3, 2025: Grant or award of PMVP derivative securities (Form 4, code A).
Jan 3, 2025: Option exercise of PMVP shares (Form 4, code M).

Other insiders filing for PMV Pharmaceuticals, Inc. (PMVP)

How to read Form 4 transaction codes